Source comparison
BPC-157 Studied Muscle Tear Research: Animal vs Human Evidence
Seiwerth et al. (2018) Rat Achilles tendon tear 10 mcg/kg daily 40% faster healing vs control Increased VEGF and collagen synthesis Surgical injury model. Not spontaneous tear Chang et al. (2014) Rat gastrocnemius muscle crush 35% reduction in recovery time En
This comparison does not assign a generated winner or score.
- Seiwerth et al. (2018)
- Rat Achilles tendon tear
- 10 mcg/kg daily
- 40% faster healing vs control
- Increased VEGF and collagen synthesis
- Surgical injury model. Not spontaneous tear
- Chang et al. (2014)
- Rat gastrocnemius muscle crush
- 35% reduction in recovery time
- Enhanced fibroblast migration and reduced inflammatory markers
- Short-term follow-up (14 days)
- Krivic et al. (2008)
- Rat quadriceps detachment
- 10 mcg/kg SC injection
- Improved tendon-to-bone healing strength by 52%
- Upregulation of FAK-paxillin pathway
- No long-term remodelling data
- Human observational (anecdotal)
- Self-reported injury recovery
- Variable (500–1000 mcg/day)
- Subjective improvement in 60–70% of cases
- Not systematically measured
- No control group, no blinding, high bias risk
- The evidence base for BPC-157 in muscle tear recovery is overwhelmingly preclinical. Peer-reviewed human trials with blinded controls don't exist as of 2026. What does exist: consistent animal data showing accelerated healing across multiple injury models, plus a growing body of anecdotal reports from athletes using the compound off-label. That's not the same as clinical validation, but it's also not random noise. The mechanism is plausible and the rodent data is reproducible.
- The limitation isn't the peptide's biological activity. It's the regulatory and funding gap. BPC-157 is a synthetic compound that can't be patented as a new molecular entity, which removes the financial incentive for pharmaceutical companies to fund expensive Phase III trials. Without FDA approval, it remains in regulatory limbo: legal to purchase for research purposes, but not approved for human therapeutic use.